Shi‐Xue Hu
- Co-authors
- William F. BenedictHong‐Ji XuHao XuMargaret A. KnowlesAnn D. ThorAndrew ArnoldVincent L. CrynsAustin L. Vickery
- Topics
- Cancer-related Molecular Pathways (11 papers)Ocular Oncology and Treatments (6 papers)Retinoids in leukemia and cellular processes (4 papers)
- Cited by
- NephrologyOncologyOphthalmology
- Partner nations
- United StatesSpainUnited Kingdom
In The Last Decade
Shi‐Xue Hu
17 papers receiving 929 citations
Peers
Comparison fields: 5 of 67
- Oncology 574
- Molecular Biology 397
- Surgery 201
- Pulmonary and Respiratory Medicine 178
- Ophthalmology 163
Countries citing papers authored by Shi‐Xue Hu
This map shows the geographic impact of Shi‐Xue Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi‐Xue Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi‐Xue Hu more than expected).
Fields of papers citing papers by Shi‐Xue Hu
This network shows the impact of papers produced by Shi‐Xue Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi‐Xue Hu. The network helps show where Shi‐Xue Hu may publish in the future.
Co-authorship network of co-authors of Shi‐Xue Hu
This figure shows the co-authorship network connecting the top 25 collaborators of Shi‐Xue Hu. A scholar is included among the top collaborators of Shi‐Xue Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shi‐Xue Hu. Shi‐Xue Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 35 | |
| 3 | 89 | |
| 4 | 49 | |
| 5 | Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis. | 74 |
| 6 | 6 | |
| 7 | Retinoblastoma protein inhibits IFN-gamma induced apoptosis. | 65 |
| 8 | 6 | |
| 9 | 2 | |
| 10 | 1 | |
| 11 | 211 | |
| 12 | 58 | |
| 13 | 128 | |
| 14 | Changes in growth and tumorigenicity following reconstitution of retinoblastoma gene function in various human cancer cell types by microcell transfer of chromosome 13. | 36 |
| 15 | Immortalization of fibroblasts from two patients with hereditary retinoblastoma. | 5 |
| 16 | Lack of nuclear RB protein staining in G0/middle G1 cells: correlation to changes in total RB protein level. | 83 |
| 17 | The retinoblastoma susceptibility gene product: a characteristic pattern in normal cells and abnormal expression in malignant cells. | 94 |
About Shi‐Xue Hu
Shi‐Xue Hu is a scholar working on Ophthalmology, Oncology and Biotechnology, having authored 17 papers that have together received 956 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (11 papers), Ocular Oncology and Treatments (6 papers) and Retinoids in leukemia and cellular processes (4 papers). The work is most often cited by research in Nephrology (158 citations), Oncology (574 citations) and Ophthalmology (163 citations). Shi‐Xue Hu has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include William F. Benedict, Hong‐Ji Xu, Hao Xu, Margaret A. Knowles, Ann D. Thor, Andrew Arnold, Vincent L. Cryns, Austin L. Vickery, Paul Cairns and Rei Takahashi. Their work appears in journals such as New England Journal of Medicine, Cancer and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.